Editor’s note: Find the latest COVID-19 news and guidance in
Anthracycline-Free Neoadjuvant Regimen Safe, Effective for TNBC
For patients with triple-negative breast cancer (TNBC), neoadjuvant carboplatin plus
Keratoacanthoma Causes and Risk Factors
A keratoacanthoma is a relatively common growth on the skin.
Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma
ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced